Danaher (DHR)
(Delayed Data from NYSE)
$256.80 USD
+4.06 (1.61%)
Updated May 31, 2024 04:05 PM ET
After-Market: $256.76 -0.04 (-0.02%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum D VGM
Brokerage Reports
0 items in cart
Danaher Corporation [DHR]
Reports for Purchase
Showing records 161 - 180 ( 500 total )
Company: Danaher Corporation
Industry: Diversified Operations
Transformational Year Validating Higher Industry Growth
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Provider: Zacks Investment Research
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Company: Danaher Corporation
Industry: Diversified Operations
COVID-19 Diagnostics: NT & LT Estimates Appear Conservative
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Provider: Zacks Investment Research
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Omicron: Life Science Tools Firms Likely Seeing Softer Landing
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Provider: Zacks Investment Research
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Provider: Zacks Investment Research
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Company: Danaher Corporation
Industry: Diversified Operations
Beats and More Coming - Positive for RGEN, WST, MRVI
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Provider: Zacks Investment Research
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Company: Danaher Corporation
Industry: Diversified Operations
Provider: Zacks Investment Research
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Provider: Zacks Investment Research
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Provider: Zacks Investment Research
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Beats Our Street High Estimates; Bookings and COVID "Durable"
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Company: Danaher Corporation
Industry: Diversified Operations
Life Science Tools - Vaccine, Bioproduction, mRNA, Cell & Gene Therapy and M&A: 2H21 Outlook
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Company: Danaher Corporation
Industry: Diversified Operations
Comprehensive Technical and Fundamental Analysis for DHR.
Provider: Stock Traders Daily
Analyst: Research Department